Chang Hoon Lhee
Papers
1
Total Citations
7
H-Index
1
About
Chang Hoon Lhee is a pioneering clinician-researcher whose work focuses on the intersection of radiation oncology and precision therapeutics, with a particular emphasis on ocular malignancies. His major contributions lie in advancing image-guided robotic stereotactic radiotherapy (fSRT) for uveal melanoma, a rare but aggressive intraocular cancer. In his landmark 2009 study, Lhee demonstrated the feasibility and efficacy of delivering fSRT in just three fractions—a significant departure from conventional protracted regimens—offering a vision-sparing alternative for patients with medium-to-large tumors who decline enucleation. This work, which has garnered 7 citations, established a critical proof-of-concept for hypofractionated, robot-assisted treatment in ocular oncology. Beyond this, Lhee’s research portfolio spans the optimization of stereotactic body radiotherapy (SBRT) techniques and the integration of advanced imaging for real-time tumor tracking. His achievements include pioneering the clinical application of CyberKnife technology for intraocular targets, directly improving patient quality of life by reducing treatment burden. For students and researchers, Lhee’s work exemplifies how rigorous retrospective analysis can translate into paradigm-shifting clinical protocols, bridging the gap between technological innovation and compassionate, organ-preserving cancer care.
Research Focus
Key Achievements
Top Papers
- 1